EVALUATION OF DIASTOLIC DYSFUNCTION IN CHILDREN WITH ASYMPTOMATIC BETA- THALASSEMIA MAJOR AN-Reference-Cited by-同舟云学术

EVALUATION OF DIASTOLIC DYSFUNCTION IN CHILDREN WITH ASYMPTOMATIC BETA- THALASSEMIA MAJOR AN

Published:2021-03-15 Issue: Volume: Page:5-7
ISSN:
Container-title:GLOBAL JOURNAL FOR RESEARCH ANALYSIS
language:en
Short-container-title:

Author:

Pal Radhabinod¹,Devendra Dhore Akshay¹,Sarkar Biswarup²

Affiliation:

1. R.G.Kar medical college, Kolkata,India.

2. Asst. Prof. R.G.Kar medical college, Kolkata, West Bengal, India.

Abstract

This was an observational cross-sectional study of 96 Patients at R.G Kar Medical College and Hospital, st Kolkata. with diagnosis of β Thalassemia major children aged between 2-12 years between 1 March, th 2016 to 28 February, 2017. A control group of 100 normal subjects matched according to age and sex, with the cases were also studied. Patients who full the inclusion and exclusion criteria were enrolled for the study after getting written informed consent. Echocardiography study was done of all the patients for assesment of diastolic function and determined whether it has any correlation with serum ferritin level in asymptomatic β Thalassemia major. It showed 66.67% of children were suffering from diastolic dysfunction, most of them were in grade 1 diastolic dysfunction followed by grade 3 diastolic dysfunction. The grade of diastolic function was correlated to the serum level of ferritin

Publisher

World Wide Journals

Reference17 articles.

1. Verma IC. The challenge of genetic disorders in India. InMolecular genetics and gene therapy- the new frontier, ScientificCommunications, Amsterdam 1994; pp11-20.

2. Bashyam MD, Bashyam L, Savithri GR et al. Molecular geneticanalyses of beta thalassemia in South India reveal rare mutations in the beta globin gene. J Hum Genet 2004; 49: 408-413.

3. Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A, Martin M, Koren G, Cohen AR.Survival in medically treated patients with homozygous beta-Thalassemia. N Engl J Med. 1994 Sep 1;331(9):574-578.

4. Walker JM. The heart in thalassaemia. Eur Heart J.2002 23:102–105.

5. Borgna-Pignatti C, Cappellini MD, De Stefano P, Del Vecchio GC, Forni GL, Gamberini MR, Ghilardi R, Piga A, Romeo MA, Zhao H, Cnaan A. Cardiac morbidity and mortality in deferoxamine or deferiprone-treated patients with thalassemia major. Blood. 2006 May 1;107(9):3733-3737.